ICARE-LCS QUERI Partnered Evaluation Initiative: Integrating Comprehensive Tobacco Treatment to Enhance Lung Cancer Screening

Part of paid clinical trials in Minneapolis, Minnesota.

Sponsor
VA Office of Research and Development
Study ID
NCT06745258
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Lung Cancer Screening
  • Tobacco Dependence Treatment

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • External Facilitation — OTHER
    Multi-component facilitation strategy to address identified implementation needs

Study Details

Lung cancer is the leading cause of cancer-related death among Veterans with 90% of cases attributable to smoking. Lung cancer screening (LCS) combined with smoking cessation saves the most lives. ICARE-LCS seeks to decrease health inequality and improve Veteran health by reducing smoking rates among Veterans receiving LCS. ICARE-LCS will use implementation methods to inform national cancer prevention efforts and build infrastructure necessary to support broad implementation of high-impact tobacco dependence treatment (TDT) processes in LCS programs.

Key Dates

Start date
Oct 1, 2026
Status verified
May 2026
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
7 participants (estimated)

Arms

  • Arm: Veterans Participating in Lung Cancer Screening who Smoke
    Veterans participating in lung cancer screening who smoke and are receiving care at participating VA medical centers
  • Arm: Participating VA Medical Centers
    Seven sites that have agreed to participate in implementation intervention

Primary Outcome Measure

Receipt of Combined Tobacco Dependence Treatment [ Time Frame: Approximately 3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Minneapolis VA Health Care System, Minneapolis, MNMinneapolisMinnesota55417-2309
Anne C Melzer, MD MS
[email protected]
(612) 725-2000
Megan E Campbell
[email protected]
(612) 725-2000
Adam Kaplan, PhD MS (SUB_INVESTIGATOR)
Anne C. Melzer, MD MS (PRINCIPAL_INVESTIGATOR)
David B. Nelson, PhD (SUB_INVESTIGATOR)
Deborah Pestka, PharmD (SUB_INVESTIGATOR)
Steven S. Fu, MD MSCE (SUB_INVESTIGATOR)

Find similar trials in Minneapolis, MN

By research site
Minneapolis VA Health Care System, Minneapolis, MN· Minneapolis, MN

Related Studies